PDL Biopharma, Inc.:企業の戦略・SWOT・財務分析

◆英語タイトル:PDL Biopharma, Inc. - Strategy, SWOT and Corporate Finance Report
◆商品コード:SWOT20MY4125
◆発行会社(調査会社):MarketLine
◆発行日:2020年2月
◆ページ数:41
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

PDL Biopharma, Inc. – Strategy, SWOT and Corporate Finance Report
Summary

PDL Biopharma, Inc. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

PDL Biopharma, Inc., (PDL or ‘the company’), formerly known as Protein Design Labs, Inc., is engaged in the research and development of humanized antibodies for cancer, immunologic diseases and other medical conditions. The company operates in the US, where it is headquartered in Incline Village, Nevada.

Scope

- Detailed information on PDL Biopharma, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting PDL Biopharma, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of PDL Biopharma, Inc. including a breakdown and examination of key business segments
- Intelligence on PDL Biopharma, Inc.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about PDL Biopharma, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of PDL Biopharma, Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess PDL Biopharma, Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on PDL Biopharma, Inc.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
PDL Biopharma, Inc.: Company Overview
PDL Biopharma, Inc.: Overview and Key Facts
PDL Biopharma, Inc.: Overview
PDL Biopharma, Inc.: Key Facts
PDL Biopharma, Inc.: Key Employees
PDL Biopharma, Inc.: Key Employee Biographies
PDL Biopharma, Inc.: Major Products and Services
PDL Biopharma, Inc.: Company History
PDL Biopharma, Inc.: Management Statement
PDL Biopharma, Inc.: Locations and Subsidiaries
PDL Biopharma, Inc.: Key Competitors
PDL Biopharma, Inc.: Company Analysis
PDL Biopharma, Inc.: Business Description
PDL Biopharma, Inc.: SWOT Analysis
PDL Biopharma, Inc.: SWOT Overview
PDL Biopharma, Inc.: Strengths
PDL Biopharma, Inc.: Weaknesses
PDL Biopharma, Inc.: Opportunities
PDL Biopharma, Inc.: Threats
PDL Biopharma, Inc.: Corporate Financial Deals Activity
PDL Biopharma, Inc.: Financial Deals Overview
PDL Biopharma, Inc.: Targets and Partners
PDL Biopharma, Inc.: Top Deals 2016 – 2020YTD*
PDL Biopharma, Inc.: Mergers and Acquisitions
PDL Biopharma, Inc.: Corporate Venturing
PDL Biopharma, Inc.: Recent Developments
PDL Biopharma, Inc.: News and Events Summary
PDL Biopharma, Inc.: Business Expansion
PDL Biopharma, Inc.: Corporate Governance
PDL Biopharma, Inc.: Financial Performance
PDL Biopharma, Inc.: Regulatory and Legal Events
PDL Biopharma, Inc.: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: PDL Biopharma, Inc.: Key Facts
Table 2: PDL Biopharma, Inc.: Key Employees
Table 3: PDL Biopharma, Inc.: Company History
Table 4: PDL Biopharma, Inc.: Locations and Subsidiaries
Table 5: PDL Biopharma, Inc.: Key Competitors
Table 6: PDL Biopharma, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 7: PDL Biopharma, Inc.: Deal Activity by Deal Type - Volume (2016 - YTD*2020)
Table 8: PDL Biopharma, Inc.: M&A Average Deal Size - Value (US$m)
Table 9: PDL Biopharma, Inc.: Targets and Partners
Table 10: PDL Biopharma, Inc.: Top Deals 2016 - 2020YTD*
Table 11: PDL Biopharma, Inc.: M&A Volume and Value Trend (2016 - YTD*2020)
Table 12: PDL Biopharma, Inc.: Corporate Venturing Volume and Value Trend (2016 - YTD*2020)
Table 13: PDL Biopharma, Inc.: Corporate Venturing by Geography (2016 - YTD*2020)
Table 14: PDL Biopharma, Inc.: News and Events Summary
Table 15: PDL Biopharma, Inc.: Business Expansion
Table 16: PDL Biopharma, Inc.: Corporate Governance
Table 17: PDL Biopharma, Inc.: Financial Performance
Table 18: PDL Biopharma, Inc.: Regulatory and Legal Events
Table 19: PDL Biopharma, Inc.: Strategy and Operations

★海外企業調査レポート[PDL Biopharma, Inc.:企業の戦略・SWOT・財務分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sihuan Pharmaceutical Holdings Group Ltd (460):製薬・医療:M&Aディール及び事業提携情報
    Summary Sihuan Pharmaceutical Holdings Group Ltd (Sihuan Pharmaceutical) is a pharmaceutical company that develops, manufactures and markets prescription drugs. The company offers products in the therapeutic areas of cardio-cerebral vascular system, central nervous system, metabolism, oncology and a …
  • Smith & Nephew Plc (SN.)-製薬・医療分野:企業M&A・提携分析
    Summary Smith & Nephew Plc (Smith & Nephew) develops, manufactures and markets medical devices for use in orthopedic reconstruction, orthopedic trauma and clinical therapies, sports medicines and advanced wound management. The company offers its products in various categories including Sports Medici …
  • Human Stem Cells Institute (ISKJ):企業の財務・戦略的SWOT分析
    Summary Human Stem Cells Institute (HSCI) is a biotech company that provides discovery, research and development, and marketing of proprietary products and services in the areas of regenerative medicine, medical genetics, bio-insurance, gene therapy and biopharmaceutics. The company offers neovascul …
  • F&C Investment Trust PLC:企業の戦略・SWOT・財務分析
    F&C Investment Trust PLC - Strategy, SWOT and Corporate Finance Report Summary F&C Investment Trust PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Endava Limited:企業の戦略・SWOT・財務情報
    Endava Limited - Strategy, SWOT and Corporate Finance Report Summary Endava Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Genedata AG-医療機器分野:企業M&A・提携分析
    Summary Genedata AG (Genedata) is a healthcare technology company that transforms data into software solutions. The company delivers enterprise solutions for data analytics that streamline research and development workflows and improve research productivity. Its products include genedata biologics, …
  • Aetna Inc:企業のM&A・事業提携・投資動向
    Aetna Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Aetna Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capita …
  • Teledyne Technologies Incorporated (TDY):石油・ガス:M&Aディール及び事業提携情報
    Summary Teledyne Technologies Incorporated (Teledyne) is a provider of enabling technologies for industrial growth markets. The company’s product portfolio comprises digital imaging sensors, cameras and systems, infrared and X-ray spectra, monitoring and control instrumentation. It also offers elect …
  • CytoBioscience Inc:医療機器:M&Aディール及び事業提携情報
    Summary CytoBioscience Inc (CytoBioscience), formerly Cytocentrics Bioscience GmbH is a biotechnology company that manufactures of medical devices for ion channel research. The company’s products include CytoPatch instrumentations. It provides services such as adult human heart, expression systems, …
  • Informa PLC (INF):企業の財務・戦略的SWOT分析
    Informa PLC (INF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • KVK-Tech Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary KVK-Tech Inc (KVK-Tech) is a developer and manufacturer of generic pharmaceuticals. The company's products include benzphetamine HCL, betaxolol, chlorphen-12, cyclobenzaprine HCL, diethylpropion HCL, hydroxyzine HCL, indomethacin extended release, phentermine hydrochloride USP, phendimetrazi …
  • Vivendi S.A. (VIV):企業の財務・戦略的SWOT分析
    Vivendi S.A. (VIV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Enphase Energy, Inc. (ENPH)-エネルギー分野:企業M&A・提携分析
    Summary Enphase Energy, Inc. (EEI), formerly PVI Solutions, Inc., is an energy management solutions provider that designs, develops, manufactures and sells microinverter system. Its semiconductor-based microinverter system converts direct current (DC) electricity to alternating current (AC) electric …
  • Mineworx Technologies Ltd:企業の戦略・SWOT・財務分析
    Mineworx Technologies Ltd - Strategy, SWOT and Corporate Finance Report Summary Mineworx Technologies Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Iconic Therapeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Iconic Therapeutics Inc (Iconic Therapeutics) is a biopharmaceutical company that provides translation of scientific insight into breakthrough medicines. The company offers development of tissue factor in angiogenesis, inflammation, and metastasis that led to develop new approach to retinal …
  • Nippon Paint Holdings Co Ltd (4612):企業の財務・戦略的SWOT分析
    Nippon Paint Holdings Co Ltd (4612) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Lixil Group Corporation (5938):企業の財務・戦略的SWOT分析
    Lixil Group Corporation (5938) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • ARCA biopharma Inc (ABIO):医療機器:M&Aディール及び事業提携情報
    Summary ARCA Biopharma Inc (ARCA), formerly Nuvelo Inc is a developer of genetically targeted therapies for cardiovascular diseases. The company’s product candidate include Gencaro, a mild vasodilator and investigational pharmacologically unique beta-blocker that is being developed for the treatment …
  • Heartland Group Holdings Ltd (HGH):企業の財務・戦略的SWOT分析
    Heartland Group Holdings Ltd (HGH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Richter Gedeon Nyrt (RICHTER):製薬・医療:M&Aディール及び事業提携情報
    Summary Richter Gedeon Nyrt (Richter) is a pharmaceutical company that develops, manufactures and commercializes a wide range of drugs including original, generic and licensed products and over-the-counter (OTC) medicines. The company’s product portfolio encompasses medicines to treat gynaecological …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆